Green Lifescience Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Green Lifescience has a total shareholder equity of ₩36.7B and total debt of ₩4.8B, which brings its debt-to-equity ratio to 13.1%. Its total assets and total liabilities are ₩44.1B and ₩7.4B respectively.
Belangrijke informatie
13.1%
Verhouding schuld/eigen vermogen
₩4.80b
Schuld
| Rente dekkingsratio | n/a |
| Contant | ₩12.73b |
| Aandelen | ₩36.70b |
| Totaal verplichtingen | ₩7.37b |
| Totaal activa | ₩44.08b |
Recente financiële gezondheidsupdates
Health Check: How Prudently Does Green Lifescience (KOSDAQ:114450) Use Debt?
Mar 26
KPX Lifescience.Co.Ltd (KOSDAQ:114450) Has Debt But No Earnings; Should You Worry?
Feb 22Recent updates
Green Lifescience Co., Ltd.'s (KOSDAQ:114450) 36% Dip In Price Shows Sentiment Is Matching Revenues
Sep 13The Market Doesn't Like What It Sees From Green Lifescience Co., Ltd.'s (KOSDAQ:114450) Revenues Yet
Jul 30Health Check: How Prudently Does Green Lifescience (KOSDAQ:114450) Use Debt?
Mar 26KPX Lifescience.Co.Ltd (KOSDAQ:114450) Has Debt But No Earnings; Should You Worry?
Feb 22Investors Who Bought KPX Lifescience.Co.Ltd (KOSDAQ:114450) Shares Three Years Ago Are Now Up 180%
Dec 31
Analyse van de financiële positie
Kortlopende schulden: A114450's short term assets (₩21.8B) exceed its short term liabilities (₩6.9B).
Langlopende schulden: A114450's short term assets (₩21.8B) exceed its long term liabilities (₩488.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: A114450 has more cash than its total debt.
Schuld verminderen: A114450's debt to equity ratio has increased from 9.2% to 13.1% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Whilst unprofitable A114450 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Voorspelling contante baan: A114450 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 5.2% per year.